genetics and epigenetics of obesity
TRANSCRIPT
-
7/22/2019 Genetics and Epigenetics of Obesity
1/22
Maturitas. 2011 May; 69(1): 4149.
doi: 10.1016/j.maturitas.2011.02.018
PMCID: PMC3213306
Genetics and epigenetics of obesity
Blanca M. Herrera, Sarah Keildson, and Cecilia M. Lindgren
Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, United Kingdom
Oxford Centre for Diabetes, Endocrinology and Metabolism University of Oxford, United Kingdom
Cecilia M. Lindgren: [email protected]
Corresponding author. Tel.: +44 1865 287598; fax: +44 1865 287664. Email: [email protected]
Received June 14, 2010; Revised February 14, 2011; Accepted February 14, 2011.
Copyright 2011 Elsevier Ireland Ltd.
This document may be redistributed and reused, subject to certain conditions.
This document was posted here by permission of the publisher. At the time of the deposit, it included all changes made during peer review,
copy editing, and publishing. The U. S. National Library of Medicine is responsible for all links within the document and for incorporating any
publisher-supplied amendments or retractions issued subsequently. The published journal article, guaranteedto be such by Elsevier, is available
for free, on ScienceDirect, at: http://dx.doi.org/10.1016/j.maturitas.2011.02.018
Abstract
Obesity results from interactions between environmental and genetic factors. Despite a relatively high
heritability of common, non-syndromic obesity (4070%), the search for genetic variants contributing
to susceptibility has been a challenging task. Genome wide association (GWA) studies have
dramatically changed the pace of detection of common genetic susceptibility variants. To date, more
than 40 genetic variants have been associated with obesity and fat distribution. However, since these
variants do not fully explain the heritability of obesity, other forms of variation, such as epigeneticsmarks, must be considered.
Epigenetic marks, or imprinting, affect gene expression without actually changing the DNA
sequence. Failures in imprinting are known to cause extreme forms of obesity (e.g. PraderWilli
syndrome), but have also been convincingly associated with susceptibility to obesity. Furthermore,
environmental exposures during critical developmental periods can affect the profile of epigenetic
marks and result in obesity.
We review the most recent evidence for genetic and epigenetic mechanisms involved in the
susceptibility and development of obesity. Only a comprehensive understanding of the underlying
genetic and epigenetic mechanisms, and the metabolic processes they govern, will allow us to
manage, and eventually prevent, obesity.
Abbreviations: BMI, body mass index; WC, waist circumference; WHR, waist:hip ratio; T2D,
type-2-diabetes; LD, linkage disequilibrium; CNV, copy number variants; PWS, PraderWilli
syndrome; QTL, quantitative trait loci; SNP, single nucleotide polymorphism
Keywords: Genetic, Epigenetic, Fat distribution, Obesity, Methylation, Imprinting
1. Introduction
Overweight and obesity are becoming more widespread with global projections of more than 2.16
billion overweight and 1.12 billion obese individuals by 2030 [1]. This clearly presents a worldwide
Sponsored Document from
MATURITAS
a a a,b,
a
b
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
2 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
2/22
clinical and public health burden, associated with social and personal criticism. It is also correlated
with an increased risk of type-2-diabetes (T2D), cardiovascular disease, cancer and mortality [2,3].
Despite intensive research, current efforts to reduce obesity by diet, exercise, education, surgery and
drug therapies are failing to provide effective long-term solutions to this epidemic.
At an individual level, obesity occurs when abnormal amounts of triglycerides are stored in adipose
tissue and released from adipose tissue as free fatty acids (FFA) with detrimental effects [4]. Excess
fat accumulation occurs when energy intake exceeds energy expenditure, although individuals
respond differently to this imbalance owing to genetic predisposition. Twin studies estimateheritability of body mass index (BMI) to be 4070% in children and adults [57], and other
anthropometric measures of obesity and regional fat distribution [skinfold thickness, waist
circumference (WC) and waist:hip ratio (WHR)] show similar heritability [512]. Furthermore, there
are ethnic differences in obesity; admixture mapping studies demonstrate that obesity correlates
closely with the percentage of ancestry derived from ethnic groups with elevated prevalence [13,14].
The goal of obesity research is to elucidate pathways and mechanisms that control obesity and to
improve prevention, management and therapy.
Here we review recent advances in identifying factors contributing to obesity susceptibility. We focus
on:
We discuss the impact of recent findings in these two areas and their joint potential to enhance
understanding of obesity susceptibility mechanisms and aetiology.
2. The identification of susceptibi lity loci for obesity
Until 2006, the main approaches used to track down common variants influencing obesity, involved
either hypothesis-free genome-wide linkage mapping in families with multiple obese subjects or
association studies within candidate genes using casecontrol samples or parentoffspring trios. The
former suffered from being underpowered for any sensible susceptibility models, as linkage is best
placed to detect variants with high penetrance. As far as we can tell, common variants with high
penetrance do not contribute substantially to risk of common forms of obesity and few, if any, robust
signals have emerged from such efforts [15,16]. The latter candidate-gene association approach has
historically been compromised by difficulties in selecting credible candidates. Selection was typically
based on hypotheses about biological mechanisms putatively involved in obesity pathogenesis but, as
the function of much of the genome is poorly characterized, it remains almost impossible to make fully
informed decisions. In addition, all too often these candidate-gene studies were conducted in sample
sets far too small to offer confident detection of variants with the range of effect sizes that are now
known to be realistic. With hindsight, it is easy to appreciate why these approaches yielded fewexamples of genuine obesitysusceptibility variants.
Consequently, over the last two decades, efforts in identifying and replicating genetic variants
predisposing individuals to common forms of obesity were largely characterized by slow progress and
limited success, in sharp contrast to the successful gene identification in monogenic and syndromic
forms of obesity [15]. The most recent edition of the Human Obesity Gene Map gives an excellent
overview of this; it lists 11 single gene mutations, 50 loci related to Mendelian syndromes relevant to
human obesity, 244 knockout or transgenic animal models and 127 candidate genes, of which slightly
less than 20% are replicated by 5 or more studies [15]. A total of 253 quantitative trait loci (QTL), for
recent successes in identification of genetic variation affecting obesity trait susceptibility;(a)
emerging evidence connecting epigenetic (heritable changes which affect gene function but do
not modify DNA sequence) events with obesity.
(b)
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
2 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
3/22
different obesity-related phenotypes, have been reported from 61 genome-wide linkage scans and of
these, only 20% are supported by more than one study [15].
Over the past three years it has become possible, from technical and economic perspectives, to
undertake hypothesis-free GWA testing in samples of sufficient size to generate convincing
association results. The advent of the GWA approach was the result of three components. The first
was the human genome sequence which subsequently enabled cataloguing genome-sequence
variation. Secondly, the International HapMap Consortium (http://www.hapmap.org) [17]taught us
that, in non-African-descent populations, extensive correlations (linkage disequilibrium, LD) betweenneighbouring single nucleotide polymorphisms (SNPs) constrain the number of independent genetic
tests required to survey the genome, such that 80% of all common variation can be sampled using
500 000 carefully selected SNPs [18,19]. Lastly, novel genotyping methods address the challenges of
massively parallel SNP-typing at high accuracy and low cost [20]. The GWA approach has been
hugely successful in identifying loci harbouring common forms of obesity (as defined by
anthropometric measures: BMI, WC and/or WHR) susceptibility genes and hereto results from a total
of 15 high-density GWAs (i.e. 300 000 SNPs, offering genome-wide coverage >65%) have been
published (Table 1). These studies combined, have yielded over 50 loci associated with obesity
(p-values
-
7/22/2019 Genetics and Epigenetics of Obesity
4/22
association for 7 of the 13 loci previously reported to influence BMI [3234]. This suggests that
variants influencing BMI might also contribute to more severe forms of obesity, which represents the
extreme, of the phenotypic spectrum rather than a distinct condition, although, this needs
confirmation in appropriately powered studies.
Recently, a large-scale meta-analysis of 249 769 individuals confirmed 14 of these previously
identified obesity susceptibility loci and identified 18 novel loci associated with BMI and overall
adiposity (Table 2) [37]. As a consequence of the increased power of this study, new signals with
lower minor allele frequencies and smaller effect sizes, compared to previously identified variants,were discovered. These results suggest that genome-wide association studies are only the first step in
the identification of the causal variants that play a role in common, overall obesity and weight
regulation and further insights into the underlying biological mechanisms and pathways will be
needed for the effective treatment and management of these traits [37].
While no consistent association has been shown between height and BMI-associated variants as a
group, three of the loci (MC4R,RBJADCY3POMCand MTCH2NDUFS3) show individual
associations with height [37]. The BMI-increasing alleles of the variants near POMCand MC4Rwere
associated with decreased and increased height respectively, and this is analogous to the effects of
severe mutations in POMCand MC4Ron height and weight [31,38].
2.1. Genetics of fat distribution
As described above, efforts to identify common and rare variants influencing BMI and risk of obesity
have emphasized a key role for neuronal regulation of overall obesity [2124,2630,3235], but until
recently provided few clues to processes responsible for variation in central obesity and fat
distribution [29,39,40]. Measures of central and general adiposity are highly correlated: BMI has an
r 0.9 with WC and 0.6 WHR. Also, WC and WHR are correlated with measures of intra-
abdominal fat, measured by magnetic resonance imaging in obese women (r 0.6 and 0.5,
respectively). Clinically, central obesity is associated with susceptibility to T2D, cardiovascular disease
and increased mortality [3]. Evidence indicates that individual variability in patterns of fat
distribution involve local, depot-specific and body-shape processes, which are probably independentof the mechanisms that control overall energy balance and general obesity. First, anthropometric
measures of central adiposity are highly heritable [41]and, after BMI correction, heritability
estimates remain high (0.6 for WC and 0.45 for WHR) [10,11,42]. Second, substantial gender-
specific differences in fat distribution, reflect specific genetic influences [43,44]. Third, inherited
lipodystrophies, which are monogenic syndromes, demonstrate that DNA variants can have specific
effects on the development and/or maintenance of specific regional fat-depots and body shape [45].
Hereto, five GWA studies of central obesity (WC and WHR) have been published [29,39,40,44,46](
Table 1) and have identified 17 novel common obesity loci. The associations of three of these loci
(MSRA; TFAP2Band NRXN3, Table 2) to WC appear to be mediated through BMI [36,37,39,44],
implying their involvement in overall adiposity. The remaining 14 loci, however, showed significant
associations with WHR, after correction for BMI, suggesting their role in body fat distribution,
independent of overall obesity. Interestingly, some of these loci showed strong sex-specific effects in
women [39,44]and in a study by Heid et al. [44], the WHR-increasing allele was shown to be
associated with an increase in WC for 14 loci in women, but only six men. This evident heterogeneity
between men and women across many of these WHR loci is a reflection of the sex-specific genetic
effects driving individual patterns of body fat.
3. Epigenetics and obesity
Epigenetics is loosely defined as the study of heritable changes which affect gene function without
2
2
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
2 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
5/22
3.1.1. DNA methylation
3.1.2. Histone modif ications
modifying the DNA sequence [47]. The maintenance of epigenetic marks through generations is
poorly understood and the notion of their transmission is contentious [48]. Epigenetic marks are
tissue specific and include DNA methylation and histone modifications which mediate biological
processes such as imprinting. As many imprinted genes are growth factors, or regulators of gene
expression controlling growth, imprinting disorders often feature obesity as one of their clinical
characteristics.
Genomic imprinting determines expression of alleles according to their maternal or paternal origin
[49]and establishes a balance between the expression of the parental alleles influencing growth [50],resulting in counteracting growth effects of paternal and maternal genomes [51]. In addition to
growth, imprinted genes are also involved in differentiation, development, viability and metabolic
functions [52]. Two main clusters of genomic imprinting are known in humans: a region at 11p15
containing several imprinted genes including IGF2,INS,KCNQ10T1(LIT1) (paternally expressed)
and H19,KCNQ1, CDKN1C,PHLDA2,KVLQT1(maternally expressed) [53]. The second cluster at
15q11q12 contains at least 7 imprinted genes, including; MKRN3,MAGEL2,NDN,SNURFSNRPN
(paternally expressed) and UBE3A,ATP10A(maternally expressed) [54].
Failures in imprinting which result in obesity by altering expression of growth and cellular
differentiation factors can arise due to numerous genetic events: translocation, inversion, duplication,
paternal disomy and hyper/hypo-methylation. For instance; paternal deletion or uniparental disomy
at 15q11q13, results in PraderWilli syndrome (PWS). A syndrome characterized by severe
(sometimes life threatening), early onset obesity caused by hyperphagia (due to dysfunction in the
satiety centre [55]). Moderate obesity appears in Albright hereditary osteodystrophy (AHO), due to
disruption of imprinting at the GNASgene (20q13.11 [50]).
3.1. Mediators of genomic imprinting
Genomic imprinting is mediated by DNA methylation as exemplified in the H19
and IGF2loci [56]. Methylation is a widespread feature of the genome, and is obtained through the
addition of a methyl group (CH3) to a cytosine positioned next to a guanine nucleotide (CpGs),
usually in regions with a high presence of CpG dinucleotides (>60%). Methylation in a promoterregion results in the repression (silencing) of gene expression [57], this effect may be achieved by a
number of mechanisms including: obstructing access to transcription factors/activators and
recruitment of co-repressors (like histone deacetylases) which alter chromatin structure [58]resulting
in failure to initiate transcription (Fig. 1).
DNA in cells is packaged as chromatin in a beads on a string
configuration. A length of 147 DNA base pairs wraps around a core histone octamer (a tetramer of
histones H3 and H4, flanked by two H2AH2B dimmers) and these nucleosome beads are
separated by DNA strings between 20 and 60 base pairs. Linker histones (H1/H5) occupy the exit
and entry of the DNA into the histone, these structures are in turn coiled into a compact helical
closed configuration [59]. Packaging DNA in this manner allows its efficient storage and isparamount for regulation of gene expression, as the closed configuration does not allow access to
transcriptional enzymes. Post translational modification of the histones by: H3 and H4
hyperacetylation in the promoter [60], methylation of the lys4 and lys36 of histone H3 open the
structure and allow gene expression. In contrast, methylation of lys9, lys20 and lys27 on H3 [60,61])
and ubiquitination of H2A present at high density CpG promoters [62]result in gene silencing
closed configuration. Further complexity is achieved by the level of methylation, so mono-, bi- or
tri-methylation may also effect the control of gene expression [63].
A feature of both methylation and histone modifications is that they are both tissue specific and can
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
2 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
6/22
vary with age (and developmental stage). Therefore, in order to place findings in an appropriate
context, it is of paramount importance that evaluation of epigenetic factors be carried out on suitable
tissues extracted at specified times [64,65](Fig. 2).
3.2. Epigenetic changes introduced during early development may increase the risk of obesity
Although birth weight (BW) is an imperfect summary index of growth, however, it has been widely
used as a proxy for foetal nutrition and intrauterine growth. Although better measurements of foetal
growth exist, BW measurements are used because they are non-intrusive, easily obtained and oftenfound in birth records, which enabled its use as in retrospective studies linking BW with adult onset
diseases [66]. Many studies focus on the hypothesis that early environmental influences induce
epigenetic variation, thereby permanently affecting metabolism and chronic disease risk. Specifically,
for obesity, it has been shown that obese mothers tend to have obese children [67], it has been shown
that clinical intervention to cause maternal weight loss can have a positive effect on reducing risk of
obesity in the offspring [68]. The mechanisms by which nutritional challenges affect the risk of
disease in later life are poorly understood. However, evidence indicates that the establishment of the
epigenome can be affected by environmental factors during critical developmental periods [69].
Possible disturbances of methylation may arise during foetal development due to lack of availability of
dietary methyl donors [7072]. Potential interactions between the environment and epigenetic
mechanisms mediating the expression of genes associated with increased BMI and adiposity, may
also be possible as suggested for; the FTOlocus is a DNA-demethylase enzyme [23], the MC4Rgene
which has reduced methylation following long-term exposure to a high fat diet [73], the PPAR
protein which interacts with histone acetyltransferases [58]during adipogenesis and on the effect of
diet on methylation ofPOMC[74]and Leptin[75].
With this in mind, it is important to consider the effect of assisted reproduction technology on
epigenetics and subsequently on obesity susceptibility. Despite small numbers, increased incidence of
PWS, when compared to background population prevalence, has been shown [76]and subtler adverse
effects may only become apparent later on in life. We are currently gaining more insight through the
use of high-throughput sequencing methods for the detection of DNA methylation patterns, and
chromatin immunoprecipitation (ChIP) used to detect histone modifications and new integrated
genomics-based technologies which are currently being developed by the human epigenome project
(http://www.epigenome.org) initiative.
4. Remaining challenges
4.1. Identifying novel loci
Despite successes in susceptibility loci identification for obesity through the first wave of GWAs, the
combined effect of the loci explains only 23% of the inherited contribution to obesity risk.
4.2. Collaborativ e stud ies to fo r larger GWA meta-analysis
The GIANT consortium is finalising the next wave of GWA meta-analysis for obesity related traits
incorporating >100 000 samples. This increase in sample size should attain sufficient power to allow
identification of common variants with even smaller effect sizes than hereto. Also, conditional
analysis using the previously identified variants will reveal whether some of the already identified loci
contain more than one independent association with obesity, which would be an additional source of
unexplored variation contributing to the missing heritability.
4.3. Obesity susceptibility associated to rare-low-frequency variants
The obesity risk alleles that have been identified so far by GWAs are quite common (2791%) in
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
2 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
7/22
European populations but the current approaches are limited in the range of minor allele frequencies
(MAF) that are detected due to the range of allele frequencies (>5% MAF) present on current
genotype arrays. The 1000 genomes project (http://www.1000genomes.org/) is designed to catalogue
low and rare frequency variants and this will lead to the design of new genotype arrays including
wider spectra of allele frequencies.
4.4. Copy number variations
Copy number variants (CNVs) are hard to detect due to technical constrains but recently [74], twocomplementary approaches have delivered the first examples of CNVs associated to obesity. The SNPs
associated with obesity at theNEGR1locus are in strong LD with a nearby CNV [32], tagging a 45-kb
deletion polymorphism which is a candidate causal-variant at this locus. Recently by analysing SNP
genotype arrays that are enriched in CNV information and applying novel CNV detecting algorithms
on these arrays deletions on chromosome 16p11.2 have been reported to be associated with extreme,
highly penetrant obesity [77,78]. Further applications of these approaches in larger sample sets
should allow a better understanding of total CNVs contribution to overall variation in obesity
susceptibility.
4.5. Characterization of associated loci and causal variants
It is not clear how much of the remaining variation will be uncovered by the aforementioned steps.
Beyond identifying more susceptibility loci, finding the causal gene(s) and variant(s) in each locus
will be necessary to allow the detailed molecular and physiological investigations that are necessary
to determine the mechanisms and pathways through which these contribute to obesity susceptibility
and ultimately allow this knowledge to be translated into better prediction and treatment options.
4.6. Integration of genetic and epigenetic information
Genetic and epigenetic factors are intimately intertwined, as epigenetic marks and DNA modifications
are the direct consequence of sequence-specific interactions between proteins and DNA [79]. The
completion of the human epigenome project will increase our understanding of the genetic and
epigenetics underlying cellular homeostasis and the integration of this knowledge with the known
environmental risks to obesity, must be applied so that it may eventually be exploited and
manipulated to appease the obesity epidemic.
5. Conclusions
The current obesity epidemic is clearly not of genetic origin per se, but due to unfavourable changes in
lifestyle and environment (the obesogenic environment). The obesogenic environment has different
effects on different individuals in the same environment, highlighting an underlying, inherited
susceptibility to obesity and fat-distribution. For more than a decade, the genetics underlying
common forms of obesity have remained elusive although the advent of the GWA approach has
started to deliver robust associations to obesity. The epigenetic contribution to common forms ofobesity are still largely unknown but, from rare syndromes and animal models we conclude that it is
likely that both genetic and environmental effects on epigenetics will in turn be associated with
obesity. We have started to identify an emerging pattern of effects acting through CNS, suggesting
that a component of an individual's response to the obesogenic environment is partly
neurobehaviourally driven. There is also some evidence of effects acting more peripherally in the
adipose tissue. Despite the success of GWAs in obesity loci identification, we still only explain a low
fraction of the inter-individual variation of obesity. Extensive work including identification of more
obesity susceptibility loci, a better understanding of the gene(s) through which the effect is executed,
as well as further molecular and physiological characterization of the associated genes, is now
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
2 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
8/22
necessary before any of these findings will lead to any useful therapeutic interventions.
Contribu tors and their role
All the authors were involved in the drafting, editing and approval of this manuscript.
Blanca M. Herrera and Sarah L. Keildson were involved in the construction of the tables and figures.
Competing interests
None.
Provenance and peer review
Commissioned and externally peer reviewed.
Acknow ledgement
C.M.L. is a Wellcome Trust Research Career Development Fellow (086596/Z/08/Z).
References
1. Kelly T., Yang W., Chen C.S., Reynolds K., He J. Global burden of obesity in 2005 and projections to
2030. Int J Obes (Lond) 2008;32(September (9)):14311437. [PubMed: 18607383]
2. Flegal K.M., Graubard B.I., Williamson D.F., Gail M.H. Cause-specific excess deaths associated
with underweight, overweight, and obesity. JAMA. 2007;298(November (17)):20282037.
[PubMed: 17986696]
3. Pischon T., Boeing H., Hoffmann K. General and abdominal adiposity and risk of death in Europe.
N Engl J Med. 2008;359(November (20)):21052120. [PubMed: 19005195]
4. ORahilly S. Human genetics illuminates the paths to metabolic disease. Nature.
2009;462(November (7271)):307314. [PubMed: 19924209]
5. Stunkard A.J., Foch T.T., Hrubec Z. A twin study of human obesity. JAMA. 1986;256(July(1)):5154. [PubMed: 3712713]
6. Turula M., Kaprio J., Rissanen A., Koskenvuo M. Body weight in the finnish twin cohort. Diabetes
Res Clin Pract. 1990;10 (Suppl. 1):S33S36. [PubMed: 2286148]
7. Wardle J., Carnell S., Haworth C.M., Plomin R. Evidence for a strong genetic influence on
childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr.
2008;87(February (2)):398404. [PubMed: 18258631]
8. Malis C., Rasmussen E.L., Poulsen P. Total and regional fat distribution is strongly influenced by
genetic factors in young and elderly twins. Obes Res. 2005;13(December (12)):21392145.
[PubMed: 16421348]
9. Moll P.P., Burns T.L., Lauer R.M. The genetic and environmental sources of body mass index
variability: the muscatine ponderosity family study. Am J Hum Genet. 1991;49(December
(6)):12431255. [PMCID: PMC1686453] [PubMed: 1746554]
10. Rose K.M., Newman B., Mayer-Davis E.J., Selby J.V. Genetic and behavioral determinants of
waisthip ratio and waist circumference in women twins. Obes Res. 1998;6(November (6)):383392.
[PubMed: 9845227]
11. Selby J.V., Newman B., Quesenberry C.P., Jr., Fabsitz R.R., King M.C., Meaney F.J. Evidence of
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
2 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
9/22
genetic influence on central body fat in middle-aged twins. Hum Biol. 1989;61(April (2)):179194.
[PubMed: 2767669]
12. Stunkard A.J., Sorensen T.I., Hanis C. An adoption study of human obesity. N Engl J Med.
1986;314(January (4)):193198. [PubMed: 3941707]
13. Redden D.T., Divers J., Vaughan L.K. Regional admixture mapping and structured association
testing: conceptual unification and an extensible general linear model. PLoS Genet. 2006;2(August
(8)):e137. [PMCID: PMC1557785] [PubMed: 16934005]
14. Williams R.C., Long J.C., Hanson R.L., Sievers M.L., Knowler W.C. Individual estimates of
European genetic admixture associated with lower body-mass index, plasma glucose, and prevalence
of type 2 diabetes in Pima Indians. Am J Hum Genet. 2000;66(February (2)):527538.
[PMCID: PMC1288106] [PubMed: 10677313]
15. Rankinen T., Zuberi A., Chagnon Y.C. The human obesity gene map: the 2005 update. Obesity
(Silver Spring) 2006;14(April (4)):529644. [PubMed: 16741264]
16. Saunders C.L., Chiodini B.D., Sham P. Meta-analysis of genome-wide linkage studies in BMI and
obesity. Obesity (Silver Spring) 2007;15(September (9)):22632275. [PubMed: 17890495]
17. A haplotype map of the human genome. Nature. 2005;437(October (7063)):12991320.[PMCID: PMC1880871] [PubMed: 16255080]
18. Barrett J.C., Cardon L.R. Evaluating coverage of genome-wide association studies. Nat Genet.
2006;38(June (6)):659662. [PubMed: 16715099]
19. Peer I., de Bakker P.I., Maller J., Yelensky R., Altshuler D., Daly M.J. Evaluating and improving
power in whole-genome association studies using fixed marker sets. Nat Genet. 2006;38(June
(6)):663667. [PubMed: 16715096]
20. Fan J.B., Chee M.S., Gunderson K.L. Highly parallel genomic assays. Nat Rev Genet.
2006;7(August (8)):632644. [PubMed: 16847463]
21. Frayling T.M., Timpson N.J., Weedon M.N. A common variant in the FTO gene is associated with
body mass index and predisposes to childhood and adult obesity. Science. 2007;316(May
(5826)):889894. [PMCID: PMC2646098] [PubMed: 17434869]
22. Zeggini E., Weedon M.N., Lindgren C.M. Replication of genome-wide association signals in UK
samples reveals risk loci for type 2 diabetes. Science. 2007;316(June (5829)):13361341.
[PMCID: PMC3772310] [PubMed: 17463249]
23. Gerken T., Girard C.A., Tung Y.C. The obesity-associated FTO gene encodes a 2-oxoglutarate-
dependent nucleic acid demethylase. Science. 2007;318(November (5855)):14691472.
[PMCID: PMC2668859] [PubMed: 17991826]
24. Wahlen K., Sjolin E., Hoffstedt J. The common rs9939609 gene variant of the fat mass- and
obesity-associated gene FTO is related to fat cell lipolysis. J Lipid Res. 2008;49(March (3)):607611.
[PubMed: 18048838]
25. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared
controls. Nature. 2007;447(June (7145)):661678. [PMCID: PMC2719288] [PubMed: 17554300]
26. Dina C., Meyre D., Gallina S. Variation in FTO contributes to childhood obesity and severe adult
obesity. Nat Genet. 2007;39(June (6)):724726. [PubMed: 17496892]
27. Scuteri A., Sanna S., Chen W.M. Genome-wide association scan shows genetic variants in the FTO
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
2 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
10/22
gene are associated with obesity-related traits. PLoS Genet. 2007;3(July (7)):e115.
[PMCID: PMC1934391] [PubMed: 17658951]
28. Loos R.J., Lindgren C.M., Li S. Common variants near MC4R are associated with fat mass, weight
and risk of obesity. Nat Genet. 2008;40(June (6)):768775. [PMCID: PMC2669167]
[PubMed: 18454148]
29. Chambers J.C., Elliott P., Zabaneh D. Common genetic variation near MC4R is associated with
waist circumference and insulin resistance. Nat Genet. 2008;40(June (6)):716718.
[PubMed: 18454146]
30. Qi L., Kraft P., Hunter D.J., Hu F.B. The common obesity variant near MC4R gene is associated
with higher intakes of total energy and dietary fat, weight change and diabetes risk in women. Hum
Mol Genet. 2008;17(November (22)):35023508. [PMCID: PMC2572696] [PubMed: 18697794]
31. Farooqi I.S., Keogh J.M., Yeo G.S., Lank E.J., Cheetham T., ORahilly S. Clinical spectrum of
obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003;348(March
(12)):10851095. [PubMed: 12646665]
32. Willer C.J., Speliotes E.K., Loos R.J. Six new loci associated with body mass index highlight a
neuronal influence on body weight regulation. Nat Genet. 2009;41(January (1)):2534.
[PMCID: PMC2695662] [PubMed: 19079261]
33. Thorleifsson G., Walters G.B., Gudbjartsson D.F. Genome-wide association yields new sequence
variants at seven loci that associate with measures of obesity. Nat Genet. 2009;41(January
(1)):1824. [PubMed: 19079260]
34. Meyre D., Delplanque J., Chevre J.C. Genome-wide association study for early-onset and morbid
adult obesity identifies three new risk loci in European populations. Nat Genet. 2009;41(February
(2)):157159. [PubMed: 19151714]
35. Cotsapas C., Speliotes E.K., Hatoum I.J. Common body mass index-associated variants confer risk
of extreme obesity. Hum Mol Genet. 2009;18(September (18)):35023507. [PMCID: PMC2729668][PubMed: 19553259]
36. Scherag A., Dina C., Hinney A. Two new Loci for body-weight regulation identified in a joint
analysis of genome-wide association studies for early-onset extreme obesity in French and German
study groups. PLoS Genet. 2010;6(4):e1000916. [PMCID: PMC2858696] [PubMed: 20421936]
37. Speliotes E.K., Willer C.J., Berndt S.I. Association analyses of 249,796 individuals reveal 18 new
loci associated with body mass index. Nat Genet. 2010;42(November (11)):937948.
[PMCID: PMC3014648] [PubMed: 20935630]
38. Farooqi I.S., Drop S., Clements A. Heterozygosity for a POMC-null mutation and increased obesity
risk in humans. Diabetes. 2006;55(September (9)):25492553. [PubMed: 16936203]
39. Lindgren C.M., Heid I.M., Randall J.C. Genome-wide association scan meta-analysis identifies
three loci influencing adiposity and fat distribution. PLoS Genet. 2009;5(June (6)):e1000508.
[PMCID: PMC2695778] [PubMed: 19557161]
40. Heard-Costa N.L., Zillikens M.C., Monda K.L. NRXN3 is a novel locus for waist circumference: a
genome-wide association study from the CHARGE consortium. PLoS Genet. 2009;5(June
(6)):e1000539. [PMCID: PMC2695005] [PubMed: 19557197]
41. Kamel E.G., McNeill G., Van Wijk M.C. Usefulness of anthropometry and DXA in predicting intra-
abdominal fat in obese men and women. Obes Res. 2000;8(January (1)):3642. [PubMed: 10678257]
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
22 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
11/22
42. Selby J.V., Newman B., Quesenberry C.P., Jr. Genetic and behavioral influences on body fat
distribution. Int J Obes. 1990;14(July (7)):593602. [PubMed: 2228394]
43. Zillikens M.C., Yazdanpanah M., Pardo L.M. Sex-specific genetic effects influence variation in
body composition. Diabetologia. 2008;51(December (12)):22332241. [PubMed: 18839131]
44. Heid I.M., Jackson A.U., Randall J.C. Meta-analysis identifies 13 new loci associated with
waisthip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet.
2010;42(November (11)):949960. [PMCID: PMC3000924] [PubMed: 20935629]
45. Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004;350(March (12)):12201234.
[PubMed: 15028826]
46. Cho Y.S., Go M.J., Kim Y.J. A large-scale genome-wide association study of Asian populations
uncovers genetic factors influencing eight quantitative traits. Nat Genet. 2009;41(May (5)):527534.
[PubMed: 19396169]
47. Bird A. Perceptions of epigenetics. Nature. 2007;447(May (7143)):396398. [PubMed: 17522671]
48. Chong S., Youngson N.A., Whitelaw E. Heritable germline epimutation is not the same as
transgenerational epigenetic inheritance. Nat Genet. 2007;39(May (5)):574575. author reply 56.
[PubMed: 17460682]
49. Reik W., Walter J. Imprinting mechanisms in mammals. Curr Opin Genet Dev. 1998;8(April
(2)):154164. [PubMed: 9610405]
50. Butler M.G. Genomic imprinting disorders in humans: a mini-review. J Assist Reprod Genet.
2009;26(SeptemberOctober (910)):477486. [PMCID: PMC2788689] [PubMed: 19844787]
51. Haig D., Graham C. Genomic imprinting and the strange case of the insulin-like growth factor II
receptor. Cell. 1991;64(March (6)):10451046. [PubMed: 1848481]
52. Smith F.M., Garfield A.S., Ward A. Regulation of growth and metabolism by imprinted genes.
Cytogenet Genome Res. 2006;113(14):279291. [PubMed: 16575191]
53. Lee M.P., Brandenburg S., Landes G.M., Adams M., Miller G., Feinberg A.P. Two novel genes in
the center of the 11p15 imprinted domain escape genomic imprinting. Hum Mol Genet. 1999;8(April
(4)):683690. [PubMed: 10072438]
54. Schweizer J., Zynger D., Francke U. In vivo nuclease hypersensitivity studies reveal multiple sites
of parental origin-dependent differential chromatin conformation in the 150 kb SNRPN transcription
unit. Hum Mol Genet. 1999;8(April (4)):555566. [PubMed: 10072422]
55. Shapira N.A., Lessig M.C., He A.G., James G.A., Driscoll D.J., Liu Y. Satiety dysfunction in
PraderWilli syndrome demonstrated by fMRI. J Neurol Neurosurg Psychiatry. 2005;76(February
(2)):260262. [PMCID: PMC1739487] [PubMed: 15654046]56. Ferguson-Smith A.C., Sasaki H., Cattanach B.M., Surani M.A. Parental-origin-specific epigenetic
modification of the mouse H19 gene. Nature. 1993;362(April (6422)):751755. [PubMed: 8469285]
57. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16(January
(1)):621. [PubMed: 11782440]
58. Choy J.S., Wei S., Lee J.Y., Tan S., Chu S., Lee T.H. DNA methylation increases nucleosome
compaction and rigidity. J Am Chem Soc. 2010;132(February (6)):17821783. [PubMed: 20095602]
59. Zhu Q., Wani A.A. Histone modifications: crucial elements for damage response and chromatin
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
22 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
12/22
restoration. J Cell Physiol. 2010;223(May (2)):283288. [PMCID: PMC2930755]
[PubMed: 20112283]
60. Litt M.D., Simpson M., Gaszner M., Allis C.D., Felsenfeld G. Correlation between histone lysine
methylation and developmental changes at the chicken beta-globin locus. Science.
2001;293(September (5539)):24532455. [PubMed: 11498546]
61. Musri M.M., Gomis R., Parrizas M. Chromatin and chromatin-modifying proteins in adipogenesis.
Biochem Cell Biol. 2007;85(August (4)):397410. [PubMed: 17713575]
62. Kallin E.M., Cao R., Jothi R. Genome-wide uH2A localization analysis highlights Bmi1-dependent
deposition of the mark at repressed genes. PLoS Genet. 2009;5(June (6)):e1000506.
[PMCID: PMC2683938] [PubMed: 19503595]
63. Lachner M., O'Sullivan R.J., Jenuwein T. An epigenetic road map for histone lysine methylation. J
Cell Sci. 2003;116(June (Pt 11)):21172124. [PubMed: 12730288]
64. Feinberg A.P. Epigenetics at the epicenter of modern medicine. JAMA. 2008;299(March
(11)):13451350. [PubMed: 18349095]
65. Feinberg A.P. Genome-scale approaches to the epigenetics of common human disease. Virchows
Arch. 2010;456(January (1)):1321. [PMCID: PMC3107986] [PubMed: 19844740]
66. Stein A.D., Zybert P.A., van de Bor M., Lumey L.H. Intrauterine famine exposure and body
proportions at birth: the Dutch hunger winter. Int J Epidemiol. 2004;33(August (4)):831836.
[PubMed: 15166208]
67. Dabelea D., Mayer-Davis E.J., Lamichhane A.P. Association of intrauterine exposure to maternal
diabetes and obesity with type 2 diabetes in youth: the SEARCH casecontrol study. Diabetes Care.
2008;31(July (7)):14221426. [PMCID: PMC2453655] [PubMed: 18375420]
68. Smith J., Cianflone K., Biron S. Effects of maternal surgical weight loss in mothers on
intergenerational transmission of obesity. J Clin Endocrinol Metab. 2009;94(November
(11)):42754283. [PubMed: 19820018]
69. Waterland R.A., Jirtle R.L. Early nutrition, epigenetic changes at transposons and imprinted
genes, and enhanced susceptibility to adult chronic diseases. Nutrition. 2004;20(January (1)):6368.
[PubMed: 14698016]
70. Waterland R.A., Michels K.B. Epigenetic epidemiology of the developmental origins hypothesis.
Annu Rev Nutr. 2007;27:363388. [PubMed: 17465856]
71. Poirier L.A. The effects of diet, genetics and chemicals on toxicity and aberrant DNA methylation:
an introduction. J Nutr. 2002;132(August (8 Suppl.)):S2336S2339.
72. Biniszkiewicz D., Gribnau J., Ramsahoye B. Dnmt1 overexpression causes genomichypermethylation, loss of imprinting, and embryonic lethality. Mol Cell Biol. 2002;22(April
(7)):21242135. [PMCID: PMC133685] [PubMed: 11884600]
73. Widiker S., Karst S., Wagener A., Brockmann G.A. High-fat diet leads to a decreased methylation
of the Mc4r gene in the obese BFMI and the lean B6 mouse lines. J Appl Genet. 2010;51(2):193197.
[PubMed: 20453306]
74. Plagemann A., Harder T., Brunn M. Hypothalamic proopiomelanocortin promoter methylation
becomes altered by early overfeeding: an epigenetic model of obesity and the metabolic syndrome. J
Physiol. 2009;587(October (Pt 20)):49634976. [PMCID: PMC2770159] [PubMed: 19723777]
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
22 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
13/22
75. Milagro F.I., Campion J., Garcia-Diaz D.F., Goyenechea E., Paternain L., Martinez J.A. High fat
diet-induced obesity modifies the methylation pattern of leptin promoter in rats. J Physiol Biochem.
2009;65(March (1)):19. [PubMed: 19588726]
76. Manipalviratn S., DeCherney A., Segars J. Imprinting disorders and assisted reproductive
technology. Fertil Steril. 2009;91(February (2)):305315. [PMCID: PMC3081604]
[PubMed: 19201275]
77. Walters R.G., Jacquemont S., Valsesia A. A new highly penetrant form of obesity due to deletions
on chromosome 16p11.2. Nature. 2010;463(February (7281)):671675. [PMCID: PMC2880448]
[PubMed: 20130649]
78. Bochukova E.G., Huang N., Keogh J. Large, rare chromosomal deletions associated with severe
early-onset obesity. Nature. 2010;463(February (7281)):666670. [PMCID: PMC3108883]
[PubMed: 19966786]
79. Ptashne M., Hobert O., Davidson E. Questions over the scientific basis of epigenome project.
Nature. 2010;464(March (7288)):487. [PubMed: 20336114]
Figures and Tables
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
22 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
14/22
Fig. 1
CpG methylation and regulation of gene expression. Unmethylated or hypomethylated DNA (usually in the
promoter region) allows binding of the transcription factors (TF) and other regulatory mechanisms which results in
transcription and mRNA production. Methylated DNA (bottom panel) obstructs binding of the TF, and in some cases
might recruit methyl-CpG binding proteins and other transcription co-repressors, blocking access of the
transcription enzymes and resulting in gene silencing.
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
22 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
15/22
Fig. 2
Histone modification. This simplified diagram of a nucleosome shows a histone octamer bead surrounded by a
DNA strand and try-methylation at lysine-9, this kind of modification exemplifies modifications found at promoter
regions of silenced genes.
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
22 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
16/22
Table 1
Overview of GWA scans or meta-analysis thereof for obesity phenotypes.
Reference Study name
(if any)
Number of samples in
discovery cohort
Ancestry of discovery
cohort
Phenotype
Frayling et al.
[20]
WTCCC 1924 Europeans BMI quantitative analysis
Scuteri et al.
[26]
Sardinia 4741 Europeans BMI waist circumference
(WC) quantitative analysis
Chambers et al.
[28]
LOLIPOP 2684 Indian Asians Insulin resistance and
related quantitative
phenotypes
Loos et al. [27] 16 876 Northern European BMI quantitative analysis
Heard-Costa et
al. [36]
The CHARGE
consortium
31 373 Europeans WC quantitative analysis
Lindgren et al.
[35]
The GIANT
consortium
38 580 Europeans WC and waist:hip-ratio
(WHR) quantitative
analysis
Cotsapas et al.
[33]
775 cases and 3197
unascertained controls
Europeans Extreme obesity/BMI
Meyre et al.
[32]
1380 and 1416 age-matched
normal-weight control
Europeans Early onset and morbid
adult obesity
Thorleifsson et
al. [31]
DeCODE 37 347 Europeans + African
Americans
BMI quantitative analysis
Willer et al.
[30]
The GIANT
consortium
32 387 Europeans BMI quantitative analysis
Hinney et al.
[79]
487 extremely obese young
cases and 442 healthy lean
controls
Europeans Extreme obesity/BMI
Scherag et al.
[34]
453 extremely obese young
cases and 435 healthy lean
controls
Europeans Extreme obesity/BMI
Cho et al. [41] KARE 8842 Asian BMI, WHR quantitative
analysis
Heid et al. [43] MAGIC 77 167 European WHR quantitative analysis
Speliotes et al.
[37]
123 865 European BMI quantitative analysis
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
22 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
17/22
Table 2
The 54 loci associated to anthropometric obesity phenotypes.
Closest gene(s) Chromosomal
location
Phenotype Associated
lead
SNP(s)
Proposed
molecular or
cellular function
Additional
phenotypes
References
TBX15WARS2 1p12 WHR rs984222 Transcription
factor involved inadipocyte and
specific adipose
depot development
Implicated in
Cousin syndrome
Heid et al.
[43]
PTBP2 1p21.3 BMI rs1555543 Speliotes et al.
[37]
NEGR1 1p31 BMI rs2815752,
rs3101336,
rs2568958
Neuronal
outgrowth
Thorleifsson et
al. [31], Willer
et al. [30],
Speliotes et al.
[37]
TNNI3K 1p31.1 BMI rs1514175 Speliotes et al.
[37]
DNM3PIGC 1q24.3 WHR rs1011731 Dominant, negative
mutations in DNM
enzymes promote
GLUT6 and GLUT8
transporters to
adipocyte cell
surface in rats.
Heid et al.
[43]
SEC16B,RASAL2 1q25 BMI rs10913469 Thorleifsson et
al. [31],
Speliotes et al.
[37]
LYPLAL1; ZC3H11B 1q41 WHR rs2605100 Encodes protein
thought to act as
triglyceride lipase
and is upregulated
in subcutaneous
adipose tissue in
obese patients
Lindgren et al.
[35], Heid et
al. [43]
SDCCAG8 1q43q44 BMI rs12145833 Scherag et al.[34]
FANCL 2p16.1 BMI rs887912 Speliotes et al.
[37]
RBJADCY3POMC 2p23.3 BMI rs713586 Rare POMC
mutations cause
human obesity
Speliotes et al.
[37]
TMEM18 2p25 BMI rs6548238,
rs2867125,
rs4854344,
Neural
development
Associated with
T2D
Willer et al.
[30],
Thorleifsson et
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
22 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
18/22
Closest gene(s) Chromosomal
location
Phenotype Associated
lead
SNP(s)
Proposed
molecular or
cellular function
Additional
phenotypes
References
rs7561317,
rs11127485
al. [31],
Scherag et al.
[34], Speliotes
et al. [37]
ZNRF3KREMEN1 2q12.1 WHR rs4823006 Kremen1 proteinforms a complex
with LDL
receptor-related
protein 6
Heid et al.[43]
LRP1B 2q22.2 BMI rs2890652 LRP1Bdeletions
seen in several
types of human
cancers
Speliotes et al.
[37]
GRB14 2q24.3 WHR rs10195252 Associated with
triglyceride and
insulin levels.
GRB14-deficient
mice exhibit
increased body
weight
Heid et al.
[43]
ADAMTS9 3p14.1 WHR rs6795735 Important for
spatial distribution
of cells in
embryonic
development
Associated with
T2D
Heid et al.
[43]
NISCHSTAB1 3p21.1 WHR rs6784615 Interacts withinsulin receptor
substrate
Heid et al.[43]
CADM2 3p21.1 BMI rs13078807 Speliotes et al.
[37]
ETV5(locus with
three genes,
strongest association
in ETV5)
3q27 BMI rs7647305 Thorleifsson et
al. [31],
Speliotes et al.
[37]
Gene desert;
GNPDA2is one of
three genes nearby
4p13 BMI rs10938397 Associated with
T2D
Willer et al.
[30], Speliotes
et al. [37]
SLC39A8 4q24 BMI rs13107325 Speliotes et al.
[37]
FLJ35779 5q13.3 BMI rs2112347 Speliotes et al.
[37]
ZNF608 5q23.2 BMI rs4836133 Speliotes et al.
[37]
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
22 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
19/22
Closest gene(s) Chromosomal
location
Phenotype Associated
lead
SNP(s)
Proposed
molecular or
cellular function
Additional
phenotypes
References
CPEB4 5q35.2 WHR rs6861681 Regulates
polyadenylation
elongation
Heid et al.
[43]
TFAP2B 6p12 WC, BMI rs987237 Lindgren et al.
[35], Spelioteset al. [37]
Locus containing
NCR3, AIF1and
BAT2
6p21 BMI rs2844479,
rs2260000,
rs1077393
Associated with
weight, not BMI
Thorleifsson et
al. [31]
VEGFA 6p21.1 WHR rs6905288 Involved in vascular
development. Key
mediator of
adipogenesis
VEGFAvariants
nominally
associated with
T2D
Heid et al.
[43]
NUDT3HMGA1 6p21.31 BMI rs206936 Speliotes et al.
[37]
PRL 6p22.2p21.3 BMI rs4712652 Meyre et al.
[32]
LY86 6p25.1 WHR rs1294421 Plays a role in
recognition of
lipopolysaccharide
Associated with
asthma
Heid et al.
[43]
RSPOS 6q22.33 WHR rs9491696 Promotes
angiogenesis and
vascular
development
Oncogene in
mouse mammary
epithelial cells
Heid et al.
[43]
NFE2L3 7p15.2 WHR rs1055144 Heid et al.
[43]
MSRA 8p23.1 WC, BMI rs7826222,
rs17150703
Lindgren et al.
[35], Scherag
et al. [34]
LRRN6C 9p21.3 BMI rs10968576 Speliotes et al.
[37]
PTER 10p12 BMI rs10508503 Meyre et al.
[32]
MTCH2(locus with
14 genes)
11p11.2 BMI rs10838738 Cellular apoptosis Willer et al.
[30], Speliotes
et al. [37]
BDNF(locus with
four genes, strongest
association near
BDNF)
11p14 BMI rs4074134,
rs4923461,
rs925946,
rs10501087,
rs6265
BDNFexpression is
regulated by
nutritional state
and MC4R
signalling
Associated with
T2D. Individuals
with WAGR
syndrome with
BDNFdeletion
have BMI >95th
percentile.BDNF
knockdown in
Thorleifsson et
al. [31],
Speliotes et al.
[37]
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
22 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
20/22
Closest gene(s) Chromosomal
location
Phenotype Associated
lead
SNP(s)
Proposed
molecular or
cellular function
Additional
phenotypes
References
mouse
hypothalamus
causes
hyperphagia and
obesity
RPL27A 11p15.4 BMI rs4929949 Speliotes et al.
[37]
ITPR2SSPN 12p21.1 WHR rs718314 Mice lacking
ITPR2and ITPR3
exhibited
hypoglycaemia
and lean body
type
Heid et al.
[43]
HOXC13 12q13.13 WHR rs1443512 Transcription
factor important in
cell spatial
distribution in
embryonic
development
Heid et al.
[43]
FAIM2(locus also
containsBCDIN3D)
12q13 BMI rs7138803 Adipocyte
apoptosis
Thorleifsson et
al. [31],
Speliotes et al.
[37]
C12orf51 12q24 WHR rs2074356 Cho et al. [41]
MTIF3GTF3A 13q12.2 BMI rs4771122 Speliotes et al.
[37]
PRKD1 14q12 BMI rs11847697 Speliotes et al.
[37]
NRXN3 14q31 WC, BMI rs10146997 Heard-Costa
et al. [36],
Speliotes et al.
[37]
MAP2K5 15q23 BMI rs2241423 Speliotes et al.
[37]
SH2B1(locus with
1925 genes)
16p11.2 BMI rs7498665,
rs8049439,
rs4788102,
rs7498665
Neuronal role in
energy homeostasis
Sh2b1-null mice
are obese and
diabetic
Willer et al.
[30],
Thorleifsson et
al. [31],
Speliotes et al.
[37]
GPRC5B 16p12.3 BMI rs12444979 Speliotes et al.
[37]
MAF 16q22q23 BMI rs1424233 Transcription
factor involved in
adipogenesis and
Meyre et al.
[32]
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
22 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
21/22
Closest gene(s) Chromosomal
location
Phenotype Associated
lead
SNP(s)
Proposed
molecular or
cellular function
Additional
phenotypes
References
insulinglucagon
regulation
FTO 16q22.2 BMI rs9939609,
rs6499640,
rs8050136,rs3751812,
rs7190492,
rs8044769,
rs1558902
Neuronal function
associated with
control of appetite
Associated with
T2D
Frayling et al.
[20], Scuteri
et al. [26],Chambers et
al. [28], Willer
et al. [30],
Thorleifsson et
al. [31], Meyre
et al. [32],
Scherag et al.
[34], Speliotes
et al. [37]
NPC1 18q11.2 BMI rs1805081 Intracellular lipid
transport
NPC1-null mice
show late-onset
weight loss and
poor food intake.
NPC1interferes
with function of
raft-associated
insulin receptor
signalling
Meyre et al.
[32]
MC4R 18q22 BMI rs17782313,
rs12970134,
rs17700144
Hypothalamic
signalling
Haplo-
insufficiency in
humans is
associated with
morbid obesity.
MC4R-deficient
mice show
hyperphagia and
obesity
Willer et al.
[30],
Thorleifsson et
al. [31], Meyre
et al. [32],
Loos et al.
[27],
Chambers et
al. [28],
Scherag et al.
[34], Speliotes
et al. [37]
KCTD15 19q13.11 BMI rs11084753,
rs29941
Willer et al.
[30],
Thorleifsson et
al. [31],
Speliotes et al.
[37]
QPTCL-GIPR 19q13.32 BMI rs2287019 Encodes incretin
receptor
Associated with
fasting and 2-h
glucose
Speliotes et al.
[37]
TMEM160 19q13.32 BMI rs3810291 Speliotes et al.
[37]
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=
22 5.1.20
-
7/22/2019 Genetics and Epigenetics of Obesity
22/22
tics and epigenetics of obesity http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213306/?report=